Razoxane in treatment of acute myeloid leukaemia.
作者信息
Shaw D, Tudhope G R
出版信息
Br Med J. 1978 Oct 14;2(6144):1089-90. doi: 10.1136/bmj.2.6144.1089-d.
Abstract
摘要
相似文献
1
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓细胞白血病
Br Med J. 1978 Oct 14;2(6144):1089-90. doi: 10.1136/bmj.2.6144.1089-d.
2
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓系白血病
Br Med J. 1978 Oct 21;2(6145):1161. doi: 10.1136/bmj.2.6145.1161.
3
Razoxane in treatment of acute myeloid leukaemia.丙亚胺治疗急性髓系白血病
Br Med J. 1978 Sep 16;2(6140):801. doi: 10.1136/bmj.2.6140.801.
4
Treatment of blast cell crisis of chronic myeloid leukemia with ICRF-159 (razoxane).用ICRF-159（丙亚胺）治疗慢性髓性白血病的原始细胞危象
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2085-7.
5
Acute myeloid leukaemia after treatment with razoxane.
Br J Dermatol. 1985 Aug;113(2):131-4. doi: 10.1111/j.1365-2133.1985.tb02054.x.
6
The treatment of acute myeliod leukaemia.急性髓系白血病的治疗
J Clin Pathol. 1974 Jan;27(1):53-4. doi: 10.1136/jcp.27.1.53.
7
Limited activity of ICRF-159 in advanced acute leukemia.ICRF - 159在晚期急性白血病中的活性有限。
Cancer Treat Rep. 1979 Jan;63(1):127-9.
8
9
Comparative observations in the treatment of acute leukaemia.急性白血病治疗中的对比观察
Haematologia (Budap). 1976;10(1):81-7.
10
[Difficulties of remission induction treatment of acute myeloblastic leukemia].
Sem Hop. 1974 May 26;50(25):1691-4.
本文引用的文献
1
Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.采用三联细胞毒性方案（DAT）治疗急性髓系白血病。
Br J Cancer. 1977 Dec;36(6):770-6. doi: 10.1038/bjc.1977.260.
2
High remission-induction rate in acute myeloid leukaemia.
Lancet. 1977 Mar 5;1(8010):497-9. doi: 10.1016/s0140-6736(77)91366-6.
3
Quality and quantity of survival in acute myeloid leukaemia.
Lancet. 1975 Oct 4;2(7936):621-4. doi: 10.1016/s0140-6736(75)90111-7.
Zotero 插件